Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The National Amyotrophic Lateral Sclerosis (ALS) Registry first Biorepository pilot study expert panel meeting : March 26-27 summary report
  • Published Date:
    2012
  • Language:
    English
Filetype[PDF-1.01 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. National Amyotrophic Lateral Sclerosis (ALS) Biorepository Governance : February 12, 2013 summary report
    Corporate Authors:
    United States. Agency for Toxic Substances and Disease Registry.
    Published Date:
    2013
    Description:
    Minutes of the Meeting, February 12, 2013Purpose: Discuss current governance practices with federal biorepositories and provide comments on proposed governance policies and procedures for the National ALS Biorepository.
    File Type:
    Filetype[PDF - 516.92 KB]
  2. Integrating a Biorepository Into the National Amyotrophic Lateral Sclerosis Registry
    Personal Author:
    Horton, D. Kevin; Kaye, Wendy; Wagner, Laurie;
    Published Date:
    Nov 2016
    Source:
    J Environ Health. 79(4):38-40.
    Description:
    As part of our continuing effort to highlight innovative approaches to improving the health and environment of communities, the Journal is pleased to publish a bimonthly column from the Agency for Toxic Substances and Disease Registry (ATSDR). ATSDR ...
    File Type:
    Filetype[PDF - 129.14 KB]
  3. ATSDR’s Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : July 22-23, 2015 summary meeting
    Corporate Authors:
    United States. Agency for Toxic Substances and Disease Registry.
    Published Date:
    5/6/16
    Description:
    Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to d...
    File Type:
    Filetype[PDF - 3.58 MB]
  4. 2016 Annual ALS Surveillance Meeting executive summary, August 3-4, 2016
    Corporate Authors:
    United States. Agency for Toxic Substances and Disease Registry.
    Published Date:
    12/7/16
    Description:
    Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to e...
    File Type:
    Filetype[PDF - 79.63 KB]
  5. Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 1-2, 2017 summary report meeting transcript
    Corporate Authors:
    United States. Agency for Toxic Substances and Disease Registry.
    Published Date:
    12/1/17
    Description:
    Amyotrophic Lateral Sclerosis (ALS) continues to be a mysterious fatal disease with no known cause(s) for approximately 90-95 percent of those diagnosed with the disease. It is for this reason that the Agency for Toxic Substances and Disease Registry...
    File Type:
    Filetype[PDF - 3.56 MB]